The FDA applied a four-part statutory test under 21 CFR 216.23(c): physical and chemical characterization, historical compounding use, evidence of effectiveness, and safety
Hydrates & Strengthens Skin Barrier Improves moisture retention and skin resilience
Practical Implementation for Research Applications For anti-aging and skin rejuvenation research protocols, implementation uses 1-2 mg daily subcutaneous injection with optional combination topical 0.5-1% GHK-Cu serum, running 8-12 week cycles with 4-6 week off periods, repeating cycles 2-3 times per year
Patients seeking weight loss should consult a physician about FDA-approved GLP-1 medications
We also have clients in Idaho, Colorado and California
For gut healing applications, some practitioners recommend dosing around meals in specific patterns